Related Experiment Video
Updated: Jun 15, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Smoking in pregnancy: a risk factor for adverse neurodevelopmental outcome in preterm infants?
U Kiechl-Kohlendorfer1, E Ralser, U Pupp Peglow
1Department of Paediatrics, Division of Neonatology, Neuropaediatrics and Metabolic Disorders, Innsbruck Medical University, Innsbruck, Austria. ursula.kohlendorfer@i-med.ac.at
Insights
Smoking during pregnancy is linked to poorer neurodevelopmental outcomes in preterm infants born before 32 weeks gestation. Reducing smoking in pregnancy is crucial for improving infant development.
Area of Science:
- Neonatal Medicine
- Developmental Pediatrics
- Public Health
Background:
- Preterm infants born before 32 weeks gestation are at high risk for neurodevelopmental delays.
- Maternal smoking during pregnancy is a known risk factor for adverse pregnancy outcomes.
Purpose of the Study:
- To investigate the association between smoking in pregnancy and neurodevelopmental outcomes at 2 years of age in preterm infants.
- To identify risk factors for delayed development in this vulnerable population.
Main Methods:
- Prospective enrollment of 181 preterm infants (gestational age <32 weeks).
- Follow-up assessment at 2 years using Bayley Scales of Infant Development II.
- Logistic regression analysis to identify risk factors for delayed motor or mental development (developmental index <85).
Main Results:
- Smoking in pregnancy, low gestational age, low birth weight, small for gestational age, chronic lung disease, intracerebral hemorrhage, periventricular leucomalacia, and retinopathy of prematurity were associated with increased risk of delayed development.
- Smoking in pregnancy, small for gestational age, and chronic lung disease remained significant predictors in multivariable analysis.
Conclusions:
- Smoking during pregnancy is a significant predictor of adverse neurodevelopmental outcomes in preterm infants.
- Strategies to reduce smoking in pregnancy should be strongly promoted to improve infant neurodevelopmental trajectories.
Aim:
To assess whether smoking in pregnancy influences neurodevelopmental outcome at 2-years of age in preterm infants with a gestational age <32 weeks.
Methods:
Between January 2003 and December 2005 we prospectively enrolled 181 infants born alive between 23 and 32 weeks of gestation; 142 infants (78.5%) completed the follow-up visit. The association between candidate risk factors and delayed motor or mental development (Bayley Scales of Infant Development II; psychomotor or mental developmental index <85) was analysed by means of logistic regression analysis.
Results:
Low maternal age, smoking in pregnancy, low gestational age, low birth weight, small for gestational age, chronic lung disease, intracerebral haemorrhage, periventricular leucomalacia, and retinopathy of prematurity (stages 3 and 4) all were associated with an increased risk for delayed development (p < 0.05, each). Smoking in pregnancy, small for gestational age and chronic lung disease maintained significance in a multivariable analysis.
Conclusion:
Smoking in pregnancy emerged as a risk predictor for adverse neurodevelopmental outcome in our study. Strategies to reduce smoking in pregnancy should be further endorsed.
More Related Videos
07:36Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
05:13Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
Related Concept Videos
Teratogenicity
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Stress Prevention and Stress Management Techniques IV
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Development of the Oral Microbiota